Jane Street
ORIC icon

Jane Street’s Oric Pharmaceuticals ORIC Stock Holding History

Jane Street’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-53,037
Closed -$672K – 12698
2026
Q1 		$672K Sell
53,037
-190,996
-78% -$2.17M ﹤0.01% 7352
2025
Q4 		$2M Buy
244,033
+181,355
+289% +$2.09M ﹤0.01% 4813
2025
Q3 		$752K Buy
62,678
+15,967
+34% +$168K ﹤0.01% 6934
2025
Q2 		$474K Buy
46,711
+15,513
+50% +$104K ﹤0.01% 7017
2025
Q1 		$174K Buy
+31,198
New +$273K ﹤0.01% 8544
2024
Q4 		– Sell
-47,849
Closed -$439K – 10237
2024
Q3 		$490K Sell
47,849
-54,892
-53% -$543K ﹤0.01% 7214
2024
Q2 		$726K Buy
+102,741
New +$920K ﹤0.01% 6382
2024
Q1 		– Sell
-35,274
Closed -$325K – 9844
2023
Q4 		$325K Buy
35,274
+8,465
+32% +$61.2K ﹤0.01% 7483
2023
Q3 		$162K Buy
+26,809
New +$220K ﹤0.01% 7746
2023
Q2 		– Sell
-173,159
Closed -$987K – 9319
2023
Q1 		$987K Buy
+173,159
New +$905K ﹤0.01% 5016
2022
Q2 		– Sell
-20,840
Closed -$111K – 10524
2022
Q1 		$111K Buy
+20,840
New +$188K ﹤0.01% 9403
2020
Q3 		– Sell
-19,161
Closed -$646K – 7694
2020
Q2 		$646K Buy
+19,161
New +$612K ﹤0.01% 4688

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's ORIC Position: Q2 2026 in Review

Jane Street sold out of Oric Pharmaceuticals (ORIC) in Q2 2026, closing a stake of 53,037 shares — an estimated $672K sold.

Jane Street first reported a position in ORIC in Q2 2020 and held it in 12 quarters. The position peaked at $2M in Q4 2025. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Jane Street reported no remaining Oric Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 53,037 Oric Pharmaceuticals shares in Q2 2026, an estimated $672K.
  • Jane Street first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • Jane Street's Oric Pharmaceuticals position peaked at $2M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.